Bursa Guard Reo (Canada)

Company: Boehringer Ingelheim Animal Health

Bursal Disease-Reovirus Vaccine

Standard & Variant, Killed Virus

0.5 mL/dose

Bursa Guard Reo Indications

This product has been shown to be effective for the vaccination of healthy chickens 12 to 13 and 20 to 21 weeks of age to provide passive immunity of progeny against standard and variant bursal disease and tenosynovitis and malabsorption due to avian reovirus. The duration of immunity has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Composition

This product is a suspension of bursal disease virus and avian reovirus emulsified in oil. It contains the Standard and Variant E strains of bursal disease virus and the 1133, 2408, and MSB strains of reovirus.

Bursal Disease Virus Origin: Bursal Tissue 100%

Reovirus Origin: Chick Embryo 100%

Directions For Use

Warm vaccine to room temperature. Shake well. Inject 0.5 mL subcutaneously or intramuscularly using aseptic technique. Vaccinate at 12-13 weeks of age and repeat at 20-21 weeks of age. Birds should be primed with live reovirus and bursal disease vaccines at least 4 weeks prior to the first use of this product.

Bursa Guard Reo Caution

Store in the dark between 2-8°C (35-46°F). Do not freeze. Do not vaccinate within 42 days before slaughter. Do not mix with other products, except as specified on the label. Use entire contents when first opened. Inactivate unused contents before disposal. In case of human exposure, contact a physician.

Warning

Humans injected with this vaccine should seek immediate medical attention. Advise medical personnel that the vaccine is an oil emulsion type.

For Veterinary Use Only

Manufactured by: Boehringer Ingelheim Animal Health USA Inc., Gainesville, GA 30501 USA, VLN/PCN 124/12D5.01

Distributed in Canada by: Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

CPN: 1182091.3